| Home | E-Submission | Sitemap | Editorial Office |  
top_img
Cancer Research and Treatment Search > Browse Articles > Search



General
Genetic Susceptibility of ACE2 and TMPRSS2 in Six Common Cancers and Possible Impacts on COVID-19
Tung Hoang, Trung Quang Nguyen, Tho Thi Anh Tran
Cancer Res Treat. 2021;53(3):650-656.   Published online December 29, 2020    DOI: https://doi.org/10.4143/crt.2020.950
                        Supplementary         Web of Science 11  Crossref 11
Cathepsin C Interacts with TNF-α/p38 MAPK Signaling Pathway to Promote Proliferation and Metastasis in Hepatocellular Carcinoma
Guo-Pei Zhang, Xiao Yue, Shao-Qiang Li
Cancer Res Treat. 2020;52(1):10-23.   Published online April 26, 2019    DOI: https://doi.org/10.4143/crt.2019.145
                           Web of Science 34  Crossref 33
ZNF488 Enhances the Invasion and Tumorigenesis in Nasopharyngeal Carcinoma Via the Wnt Signaling Pathway Involving Epithelial Mesenchymal Transition
Dan Zong, Li Yin, Qian Zhong, Wen-jie Guo, Jian-hua Xu, Ning Jiang, Zhi-rui Lin, Man-zhi Li, Ping Han, Lin Xu, Xia He, Mu-sheng Zeng
Cancer Res Treat. 2016;48(1):334-344.   Published online March 12, 2015    DOI: https://doi.org/10.4143/crt.2014.311
                           Web of Science 21  Crossref 19
Significance of Cellular Senescence in Aging and Cancer
Angela Grimes, Sathees B.C. Chandra
Cancer Res Treat. 2009;41(4):187-195.   Published online December 31, 2009    DOI: https://doi.org/10.4143/crt.2009.41.4.187
                           Crossref 31
Activation of ATM-dependent DNA Damage Signal Pathway by a Histone Deacetylase Inhibitor, Trichostatin A
Jong-Soo Lee
Cancer Res Treat. 2007;39(3):125-130.   Published online September 30, 2007    DOI: https://doi.org/10.4143/crt.2007.39.3.125
                           Crossref 14
Proteolytic Regulation of Retinoblastoma Family Protein p107 by Ubiquitin - proteasome Pathway
J S Jang, B K Park, S G Hwang
J Korean Cancer Assoc. 2000;32(2):417-421.
      
Genomic Characteristics and Its Therapeutic Implications in Breast Cancer Patients with Detectable Molecular Residual Disease
Shu Zhang, Yan Jiang, Lu Zhou, Jing Xu, Gang Zhang, Lu Shen, Yan Xu
Received September 21, 2023   Accepted December 3, 2023   Published online December 5, 2023
DOI: https://doi.org/10.4143/crt.2023.1059    
[Accepted]
      
Korean Cancer Association
E-Submission
EndNote Output Style
Email Alert
Journal Impact Factor 4.6
SCImago Journal & Country Rank
PubMed Central
MEDLINE/PubMed
Scopus
KoreaMed
KoMCI
ScienceCentral
GoogleScholar
Similarity Check
Crossref Cited-by Linking
CrossMark
Funder Registry
Metadata
ORCID
COPE
Editorial Office
Korean Cancer Association
Room 1824, Gwanghwamun Officia
92 Saemunan-ro, Jongno-gu, Seoul 03186, Korea
TEL: +82-2-3276-2410   FAX: +82-2-792-1410   E-mail: journal@cancer.or.kr
About |  Browse Articles |  Current Issue |  For Authors and Reviewers
Copyright © Korean Cancer Association.                 Developed in M2PI